Can a woman who had a hysterectomy for endometriosis but retained only one ovary develop recurrent endometriosis two years after the surgery?

Can Endometriosis Recur After Hysterectomy with One Ovary Retained?

Yes, a woman who had a hysterectomy for endometriosis but retained one ovary can absolutely develop recurrent endometriosis two years after surgery, and this is actually a well-documented phenomenon with significant clinical implications.

Risk of Recurrence with Ovarian Conservation

The evidence is clear and concerning: retaining ovarian tissue after hysterectomy for endometriosis carries a substantially elevated risk of disease recurrence. The most compelling data shows that patients who undergo hysterectomy with ovarian conservation have:

• 6.1 times greater risk of developing recurrent pain compared to those who had complete oophorectomy 1
• 8.1 times greater risk of requiring reoperation 1
• 62% experienced recurrent pain when ovarian tissue was preserved, versus only 10% when all ovarian tissue was removed 1
• 31% required reoperation with ovarian conservation versus only 3.7% without 1

A more recent population-based study of 4,489 patients confirmed these findings, showing that 13% of patients who underwent hysterectomy alone (both ovaries conserved) required at least one reoperation compared to only 5% of those who had bilateral salpingo-oophorectomy 2.

Why Recurrence Occurs

The mechanism is straightforward: residual ovarian tissue continues to produce estrogen, which stimulates any remaining endometriotic implants. Even small ovarian fragments can hypertrophy under increased gonadotropin stimulation, become functional, and reactivate endometriosis 3. This can occur even when surgeons believe they have completely excised all disease.

Timeline and Patterns

Recurrence within two years is entirely consistent with the natural history of this disease. Most recurrences occur within the first 3 years after surgery 4, 5. The guideline evidence indicates that up to 44% of women experience symptom recurrence within one year after surgical treatment 4.

Critical Surgical Factors

The likelihood of recurrence is directly related to:

• Completeness of initial excision: Incomplete removal of endometriotic lesions is the most predominant reason for recurrence 6
• Presence of deep infiltrating endometriosis: Advanced stages show particularly high recurrence rates of 62% when ovaries are conserved 6
• Residual disease: Any endometriotic implants left behind will be stimulated by the functioning ovary

Clinical Implications

For your patient with one retained ovary at two years post-hysterectomy:

• Recurrence should be high on the differential for any new or persistent pelvic pain
• The retained ovary is providing ongoing estrogen stimulation to any residual endometriotic tissue
• Endometriosis can recur not just in the pelvis but in distant sites (diaphragm, bowel, bladder) 7
• Diagnostic evaluation should include transvaginal ultrasound with specific endometriosis protocols or MRI pelvis without and with IV contrast 8

Management Considerations

If recurrence is confirmed or strongly suspected:

• Medical management options include GnRH agonists, progestins (medroxyprogesterone acetate 200 mg daily), or oral contraceptives 4
• Surgical options may include excision of recurrent lesions with or without removal of the remaining ovary
• The decision regarding oophorectomy must weigh the 6-8 fold increased risk of recurrence/reoperation against the consequences of premature surgical menopause in a younger patient

Important Caveats

• Even with bilateral oophorectomy, recurrence can still occur (though at much lower rates of 3-10%) 2, 1
• Hormone replacement therapy after bilateral oophorectomy is not contraindicated and does not significantly increase recurrence risk (3.5% recurrence rate) 4, 6
• About 40% of patients do not fill hormone replacement therapy prescriptions after bilateral oophorectomy, which carries significant health consequences 2

Bottom line: Your patient's scenario—endometriosis recurrence two years after hysterectomy with one ovary retained—represents a predictable and common clinical pattern that should prompt thorough evaluation and consideration of both medical and surgical treatment options.